Seventeen placebo-controlled trials across seven antibodies yielded statistically significant but clinically small mean ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...

After years of promise, amyloid-targeting drugs may mark not a breakthrough, but a turning point toward rethinking ...

I have been following the story here of the newest Alzheimers drugs, the first to show that they can actually slow the ...

The study, titled “GenAI-Powered Framework for Reliable Sentiment Labeling in Drug Safety Monitoring,” published in Applied ...

By Sneha S K April 16 (Reuters) - The U.S. Food and Drug Administration should be more transparent when granting accelerated ...